A review of recent studies on malondialdehyde as toxic molecule and biological marker of oxidative stress

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 15, Issue 4, 2005, Pages 316-328

  Del Rio, Daniele ^a   Stewart, Amanda J ^b   Pellegrini, Nicoletta ^a  

^a UNIVERSITY OF PARMA   (Italy)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Malondialdehyde; Methods; Oxidative stress; Toxicity

Indexed keywords

EID: 23944478990     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.numecd.2005.05.003     Document Type: Short Survey

References (72)

1. Ceconi C, Boraso A, Cargnoni A, Ferrari R. Oxidative stress in cardiovascular disease: myth or fact? Arch Biochem Biophys 2003;420:217-21.
2. Sohal RS, Mockett RJ, Orr WC. Mechanisms of aging: an appraisal of the oxidative stress hypothesis. Free Radic Biol Med 2002;33:575-86.
3. Uchida K. Role of reactive aldehyde in cardiovascular diseases. Free Radic Biol Med 2000;28:1685-96.
4. Pryor WA, Stanley JP. A suggested mechanism for the production of malonaldehyde during the autoxidation of polyunsaturated fatty acids. Nonenzymatic production of prostaglandin endoperoxides during autoxidation (Letter). J Org Chem 1975;40:3615-7.
5. Frankel EN, Neff WE. Formation of malonaldehyde from lipid oxidation products. Biochim Biophys Acta 1983;754:264-70.
6. Esterbauer H, Schaur RJ, Zollner H. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic Biol Med 1991;11:81-128.
7. Hecker M, Ullrich V. On the mechanism of prostacyclin and thromboxane A2 biosynthesis. J Biol Chem 1989;264:141-50.
8. Marnett LJ. Lipid peroxidation-DNA damage by malondialdehyde. Mutat Res 1999;424:83-95.
9. VanderVeen LA, Hashim MF, Shyr Y, Marnett LJ. Induction of frameshift and base pair substitution mutations by the major DNA adduct of the endogenous carcinogen malondialdehyde. Proc Natl Acad Sci U S A 2003;100:14247-52.
10. Niedernhofer LJ, Daniels JS, Rouzer CA, Greene RE, Marnett LJ. Malondialdehyde, a product of lipid peroxidation, is mutagenic in human cells. J Biol Chem 2003;278:31426-33.
11. Voitkun V, Zhitkovich A. Analysis of DNA-protein cross-linking activity of malondialdehyde in vitro. Mutat Res 1999;424:97-106.
12. Palinski W, Ord VA, Plump AS, Breslow JL, Steinberg D, Witztum JL. ApoE-deficient mice are a model of lipoprotein oxidation in atherogenesis. Demonstration of oxidation-specific epitopes in lesions and high titers of autoantibodies to malondialdehyde-lysine in serum. Arterioscler Thromb 1994;14:605-16.
13. Slatter DA, Bolton CH, Bailey AJ. The importance of lipid-derived malondialdehyde in diabetes mellitus. Diabetologia 2000;43:550-7.
14. Knight JA, Pieper RK, McClellan L. Specificity of the thiobarbituric acid reaction: its use in studies of lipid peroxidation. Clin Chem 1988;34:2433-8.
15. Yagi K. A simple fluorometric assay for lipoperoxide in blood plasma. Biochem Med 1976;15:212-6.
16. Templar J, Kon SP, Milligan TP, Newman DJ, Raftery MJ. Increased plasma malondialdehyde levels in glomerular disease as determined by a fully validated HPLC method. Nephrol Dial Transplant 1999;14:946-51.
17. Chirico S. High-performance liquid chromatography-based thiobarbituric acid tests. Methods Enzymol 1994;233:314-8.
18. Agarwal R, Chase SD. Rapid, fluorimetric-liquid chromatographic determination of malondialdehyde in biological samples. J Chromatogr B Analyt Technol Biomed Life Sci 2002;775:121-6.
19. Del Rio D, Pellegrini N, Colombi B, Bianchi M, Serafini M, Torta F, et al. Rapid fluorimetric method to detect total plasma malondialdehyde with mild derivatization conditions. Clin Chem 2003;49:690-2.
20. Espinosa-Mansilla A, Durán Merás I, Salinas López F. Kinetic behaviour of the malonaldehyde-thiobarbituric acid reaction, kinetic-fluorimetric determination of malonaldehyde in human serum. Anal Chim Acta 1996;320:125-32.
21. Sheu JY, Ku HP, Tseng WC, Chen MT, Tsai LY, Huang YL. Determination of thiobarbituric acid adduct of malondialdehyde using on-line microdialysis coupled with high-performance liquid chromatography. Anal Sci 2003;19:621-4.
22. Karatas F, Karatepe M, Baysar A. Determination of free malondialdehyde in human serum by high-performance liquid chromatography. Anal Biochem 2002;311:76-9.
23. Wilson DW, Metz HN, Graver LM, Rao PS. Direct method for quantification of free malondialdehyde with high-performance capillary electrophoresis in biological samples. Clin Chem 1997;43:1982-4.
24. Sim AS, Salonikas C, Naidoo D, Wilcken DE. Improved method for plasma malondialdehyde measurement by high-performance liquid chromatography using methyl malondialdehyde as an internal standard. J Chromatogr B Analyt Technol Biomed Life Sci 2003;785:337-44.
25. Steghens JP, van Kappel AL, Denis I, Collombel C. Diaminonaphthalene, a new highly specific reagent for HPLC-UV measurement of total and free malondialdehyde in human plasma or serum. Free Radic Biol Med 2001;31:242-9.
26. Cighetti G, Debiasi S, Paroni R, Allevi P. Free and total malondialdehyde assessment in biological matrices by gas chromatography-mass spectrometry: what is needed for an accurate detection. Anal Biochem 1999;266:222-9.
27. Cighetti G, Allevi P, Anastasia L, Bortone L, Paroni R. Use of methyl malondialdehyde as an internal standard for malondialdehyde detection: validation by isotope-dilution gas chromatography-mass spectrometry. Clin Chem 2002;48:2266-9.
28. Stalikas CD, Konidari CN. Analysis of malondialdehyde in biological matrices by capillary gas chromatography with electron-capture detection and mass spectrometry. Anal Biochem 2001;290:108-15.
29. Suttnar J, Masova L, Dyr JE. Influence of citrate and EDTA anticoagulants on plasma malondialdehyde concentrations estimated by high-performance liquid chromatography. J Chromatogr B Biomed Sci Appl 2001;751:193-7.
30. Larstad M, Ljungkvist G, Olin AC, Toren K. Determination of malondialdehyde in breath condensate by high-performance liquid chromatography with fluorescence detection. J Chromatogr B Analyt Technol Biomed Life Sci 2002;766:107-14.
31. Korchazhkina O, Exley C, Andrew Spencer S. Measurement by reversed-phase high-performance liquid chromatography of malondialdehyde in normal human urine following derivatisation with 2,4-dinitrophenylhydrazine. J Chromatogr B Analyt Technol Biomed Life Sci 2003;794:353-62.
32. Doerge DR, Yi P, Churchwell MI, Preece SW, Langridge J, Fu PP. Mass spectrometric analysis of 2-deoxyribonucleoside and 2′-deoxyribonucleotide adducts with aldehydes derived from lipid peroxidation. Rapid Commun Mass Spectrom 1998;12:1665-72.
33. Otteneder M, Plastaras JP, Marnett LJ. Reaction of malondialdehyde-DNA adducts with hydrazines-development of a facile assay for quantification of malondialdehyde equivalents in DNA. Chem Res Toxicol 2002;15:312-8.
34. Rouzer CA, Chaudhary AK, Nokubo M, Ferguson DM, Reddy GR, Blair IA, et al. Analysis of the malondialdehyde-2′-deoxyguanosine adduct pyrimidopurinone in human leukocyte DNA by gas chromatography/electron capture/negative chemical ionization/mass spectrometry. Chem Res Toxicol 1997;10:181-8.
35. Hakala K, Auriola S, Koivisto A, Lonnberg H. Mass spectrometric (HPLC/ESI-MS/MS) quantification of pyrimido [1,3-a]purin-10(3H)-one, a guanine adduct formed by reaction of malondialdehyde with DNA. J Pharm Biomed Anal 1999;21:1053-61.
36. Yi P, Sun X, Doerge DR, Fu PP. An improved 32P-postlabeling/high- performance liquid chromatography method for the analysis of the malondialdehye-derived 1, N2-propanodeoxyguanosine DNA adduct in animal and human tissues. Chem Res Toxicol 1998;11:1032-41.
37. Leuratti C, Singh R, Lagneau C, Farmer PB, Plastaras JP, Marnett LJ, et al. Determination of malondialdehyde-induced DNA damage in human tissues using an immunoslot blot assay. Carcinogenesis 1998;19:1919-24.
38. Otteneder M, Scott Daniels J, Voehler M, Marnett LJ. Development of a method for determination of the malondialdehyde-deoxyguanosine adduct in urine using liquid chromatography-tandem mass spectrometry. Anal Biochem 2003;315:147-51.
39. Gonenc A, Ozkan Y, Torun M, Simsek B. Plasma malondialdehyde (MDA) levels in breast and lung cancer patients. J Clin Pharm Ther 2001;26:141-4.
40. Young IS, Trimble ER. Measurement of malondialdehyde in plasma by high performance liquid chromatography with fluorimetric detection. Ann Clin Biochem 1991;28:504-8.
41. Akbulut H, Akbulut KG, Icli F, Buyukcelik A. Daily variations of plasma malondialdehyde levels in patients with early breast cancer. Cancer Detect Prev 2003;27:122-6.
42. Gonca Akbulut K, Gonul B, Akbulut H. Differential effects of pharmacological doses of melatonin on malondialdehyde and glutathione levels in young and old rats. Gerontology 1999;45:67-71.
43. Kolanjiappan K, Manoharan S, Kayalvizhi M. Measurement of erythrocyte lipids, lipid peroxidation, antioxidants and osmotic fragility in cervical cancer patients. Clin Chim Acta 2002;326:143-9.
44. Cynamon HA, Isenberg JN, Nguyen CH. Erythrocyte malondialdehyde release in vitro: a functional measure of vitamin E status. Clin Chim Acta 1985;151:169-76.
45. Manju V, Kalaivani Sailaja J, Nalini N. Circulating lipid peroxidation and antioxidant status in cervical cancer patients: a case-control study. Clin Biochem 2002;35:621-5.
46. Bakan E, Taysi S, Polat MF, Dalga S, Umudum Z, Bakan N, et al. Nitric oxide levels and lipid peroxidation in plasma of patients with gastric cancer. Jpn J Clin Oncol 2002;32:162-6.
47. Satoh K. Serum lipid peroxide in cerebrovascular disorders determined by a new colorimetric method. Clin Chim Acta 1978;90:37-43.
48. Bakan N, Taysi S, Yilmaz O, Bakan E, Kuskay S, Uzun N, et al. Glutathione peroxidase, glutathione reductase, Cu-Zn superoxide dismutase activities, glutathione, nitric oxide, and malondialdehyde concentrations in serum of patients with chronic lymphocytic leukemia. Clin Chim Acta 2003;338:143-9.
49. Jain SK, McVie R, Duett J, Herbst JJ. Erythrocyte membrane lipid peroxidation and glycosylated hemoglobin in diabetes. Diabetes 1989;38:1539-43.
50. Yoneyama Y, Sawa R, Suzuki S, Doi D, Yoneyama K, Otsubo Y, et al. Relationship between plasma malondialdehyde levels and adenosine deaminase activities in preeclampsia. Clin Chim Acta 2002;322:169-73.
51. Chirico S, Smith C, Marchant C, Mitchinson MJ, Halliwell B. Lipid peroxidation in hyperlipidaemic patients. A study of plasma using an HPLC-based thiobarbituric acid test. Free Radic Res Commun 1993;19:51-7.
52. Orhan HG, Ozgunes H, Beksac MS. Correlation between plasma malondialdehyde and ceruloplasmin activity values in preeclamptic pregnancies. Clin Biochem 2001;34:505-6.
53. Richard MJ, Arnaud J, Jurkovitz C, Hachache T, Meftahi H, Laporte F, et al. Trace elements and lipid peroxidation abnormalities in patients with chronic renal failure. Nephron 1991;57:10-5.
54. Ilhan N, Ilhan N, Simsek M. The changes of trace elements, malondialdehyde levels and superoxide dismutase activities in pregnancy with or without preeclampsia. Clin Biochem 2002;35:393-7.
55. Dierckx N, Horvath G, van Gils C, et al. Oxidative stress status in patients with diabetes mellitus: relationship to diet. Eur J Clin Nutr 2003;57:999-1008.
56. Nielsen F, Mikkelsen BB, Nielsen JB, Andersen HR, Grandjean P. Plasma malondialdehyde as biomarker for oxidative stress: reference interval and effects of life-style factors. Clin Chem 1997;43:1209-14.
57. Martin-Gallan P, Carrascosa A, Gussinye M, Dominguez C. Biomarkers of diabetes-associated oxidative stress and antioxidant status in young diabetic patients with or without subclinical complications. Free Radic Biol Med 2003;34:1563-74.
58. Wasowicz W, Neve J, Peretz A. Optimized steps in fluorometric determination of thiobarbituric acid-reactive substances in serum: importance of extraction pH and influence of sample preservation and storage. Clin Chem 1993;39:2522-6.
59. Polidori MC, Savino K, Alunni G, Freddio M, Senin U, Sies H, et al. Plasma lipophilic antioxidants and malondialdehyde in congestive heart failure patients: relationship to disease severity. Free Radic Biol Med 2002;32:148-52.
60. Suttnar J, Cermak J, Dyr JE. Solid-phase extraction in malondialdehyde analysis. Anal Biochem 1997;249:20-3.
61. Tamer L, Sucu N, Polat G, et al. Decreased serum total antioxidant status and erythrocyte-reduced glutathione levels are associated with increased serum malondialdehyde in atherosclerotic patients. Arch Med Res 2002;33:257-60.
62. Boaz M, Matas Z, Biro A, Katzir Z, Green M, Fainaru M, et al. Serum malondialdehyde and prevalent cardiovascular disease in hemodialysis. Kidney Int 1999;56:1078-83.
63. Boaz M, Matas Z, Biro A, Katzir Z, Green M, Fainaru M, et al. Comparison of hemostatic factors and serum malondialdehyde as predictive factors for cardiovascular disease in hemodialysis patients. Am J Kidney Dis 1999;34:438-44.
64. Bird RP, Draper HH, Bird RP, Draper HH. Comparative studies on different methods of malonaldehyde determination. Methods Enzymol 1984;105:299-305.
65. Ozden M, Maral H, Akaydin D, Cetinalp P, Kalender B. Erythrocyte glutathione peroxidase activity, plasma malondialdehyde and erythrocyte glutathione levels in hemodialysis and CAPD patients. Clin Biochem 2002;35:269-73.
66. Yoshioka T, Kawada K, Shimada T, Mori M. Lipid peroxidation in maternal and cord blood and protective mechanism against activated-oxygen toxicity in the blood. Am J Obstet Gynecol 1979;135:372-6.
67. Loguercio C, Federico A. Oxidative stress in viral and alcoholic hepatitis. Free Radic Biol Med 2003;34:1-10.
68. Delibas N, Ozcankaya R, Altuntas I. Clinical importance of erythrocyte malondialdehyde levels as a marker for cognitive deterioration in patients with dementia of Alzheimer type: a repeated study in 5-year interval. Clin Biochem 2002;35:137-41.
69. Chi CH, Shiesh SC, Lin XZ. Total antioxidant capacity and malondialdehyde in acute abdominal pain. Am J Emerg Med 2002;20:79-82.
70. Leuratti C, Watson MA, Deag EJ, Welch A, Singh R, Gottschalg E, et al. Detection of malondialdehyde DNA adducts in human colorectal mucosa: relationship with diet and the presence of adenomas. Cancer Epidemiol Biomarkers Prev 2002;11:267-73.
71. Zhang Y, Chen SY, Hsu T, Santella RM. Immunohistochemical detection of malondialdehyde-DNA adducts in human oral mucosa cells. Carcinogenesis 2002;23:207-11.
72. Sander CS, Hamm F, Elsner P, Thiele JJ. Oxidative stress in malignant melanoma and non-melanoma skin cancer. Br J Dermatol 2003;148:913-22.